Comparative lipid-lowering effects of policosanol and atorvastatin: A randomized, parallel, double-blind, placebo-controlled trial

This publication has 21 references indexed in Scilit:

• Meta-Analysis of Natural Therapies for Hyperlipidemia: Plant Sterols and Stanols versus Policosanol
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005
• Role of Policosanols in the Prevention and Treatment of Cardiovascular Disease
  Published by Oxford University Press (OUP) ,2003
• Antiplatelet effects of policosanol (20 and 40 mg/day) in healthy volunteers and dyslipidaemic patients
  Clinical and Experimental Pharmacology and Physiology, 2002
• Evolution of NCEP guidelines: ATP1‐ATPIII risk estimation for coronary heart disease in 2002
  Clinical Cardiology, 2002
• Policosanol: Clinical pharmacology and therapeutic significance of a new lipid-lowering agent
  American Heart Journal, 2002
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
  JAMA, 1998
• Cholesterol-lowering effect of policosanol on rabbits with hypercholesterolaemia induced by a wheat starch-casein diet
  British Journal of Nutrition, 1997
• Toxicity of policosanol in beagle dogs: one-year study
  Toxicology Letters, 1994